 HANOVER, MD, Nov. 02, 2022 GLOBE NEWSWIRE -- Processa Pharmaceuticals, Inc. Nasdaq: PCSA, a clinical stage biopharmaceutical company developing products to improve the survival andor quality of life for patients who have an unmet medical need condition announces today it will host a conference call and live webcast on November 8, 2022, at 4:30 p.m. EST to discuss its third quarter 2022 results and provide an update on its clinical pipeline. 